5-fluoroindole-2-carboxylic acid has been researched along with Paralysis in 1 studies
5-fluoroindole-2-carboxylic acid: N-methyl-D-aspartate receptor antagonist
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakshi, R | 1 |
| Faden, AI | 1 |
1 other study available for 5-fluoroindole-2-carboxylic acid and Paralysis
| Article | Year |
|---|---|
Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects.
Topics: Animals; Dynorphins; Glycine; Indoles; Injections, Spinal; Kynurenic Acid; Male; Paralysis; Rats; Ra | 1990 |